BioMark Diagnostics Inc.
BMKDF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,482 | $157 | $72 | $383 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $161 | $43 | $34 | $82 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $20 | $34 |
| Total Curr. Assets | $2,642 | $200 | $126 | $499 |
| Property Plant & Equip (Net) | $454 | $852 | $589 | $969 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $3 | $3 | $3 | $3 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $35 | $34 | $14 | $0 |
| Total NC Assets | $492 | $889 | $606 | $973 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,134 | $1,089 | $732 | $1,472 |
| Liabilities | – | – | – | – |
| Payables | $267 | $144 | $220 | $128 |
| Short-Term Debt | $293 | $1,092 | $1,434 | $443 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $8 | $0 | $10 | $12 |
| Other Curr. Liab. | $663 | $8 | $0 | $1,822 |
| Total Curr. Liab. | $1,233 | $1,244 | $1,664 | $1,501 |
| LT Debt | $161 | $454 | $217 | $606 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $161 | $454 | $217 | $606 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $454 | $806 | $499 | $809 |
| Total Liabilities | $1,393 | $1,699 | $1,882 | $2,107 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13,782 | $10,139 | $8,239 | $7,121 |
| Retained Earnings | -$15,773 | -$13,450 | -$11,978 | -$10,118 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $3,732 | $2,702 | $2,590 | $2,361 |
| Total Equity | $1,741 | -$610 | -$1,150 | -$636 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,134 | $1,089 | $732 | $1,472 |
| Net Debt | -$2,028 | $1,389 | $1,579 | $667 |